BiondVax Pharmaceuticals’ $8 Million Public Offering

Sichenzia Ross Ference represented Aegis Capital Corp. as sole book running manager in the offering.BiondVax Pharmaceuticals executed the $8 Million underwritten public offering. The offering consisted of…